SIBO – A More Intelligent Way to View and Tackle Small Intestinal Bacterial Overgrowth​

I launched my microbiome educational platform four months ago, and things are really starting to pick up. My most popular protocol has been for SIBO. Apparently, there are many people who have been told that they have small intestinal bacterial overgrowth. But this is not a stand-alone condition. In fact, I don’t think I can name one, aside from something purely genetic. For someone who has a SIBO diagnosis, it’s a part of a larger picture. For those reading this, they are probably saying to themselves, “yeah, I also have IBS, or anxiety, or I don’t sleep well, I have an auto-immune disease, etc.” These things are all connected. 

In my new presentation entitled, “SIBO – A More Intelligent Way to View and Tackle Small Intestinal Bacterial Overgrowth,” as usual, I touch on the microbial fingerprint of this condition. As expected, we see the same suspects. Health-promoting bacteria are significantly reduced in the microbiomes of those with SIBO/IBS as compared to healthy controls. And of course, on the other hand, the abundance is reversed when it comes to the classic opportunistic pathogens I so frequently highlight. And in SIBO, the colonic dysbiosis works its way up into the small intestine.  

I touch on the proven SIBO risk factor, of PPI use. As always, I cite for you the references, and extract the most relevant data. PPIs just aren’t a risk factor for SIBO, they are a risk factor for just about everything. They are horrible for the microbiome, and the microbiome effects your health in so many ways. You can learn much more about this in my presentation entitled, “Stomach acid blockers and their effects on the microbiome.” 

I also highlight the connection between gut motility and SIBO. There can be several factors which contribute to this, data with which you should be aware. Thankfully there is a healthy and natural way to tackle this. 

I spend a fair amount of time on the connection between IBS and SIBO. Basically, SIBO is IBS of the small intestine. Again, I cite published papers, which you’re welcome to read. In fact, below this content, I have all of the hotlinks to the papers I cited in this video. So, it’s very easy to fact-check me.  

My information comes from thousands of hours of work. Previously, as the director of medical education for a microbiome firm, and now on my own, I dedicate a tremendous amount of time reading as much of the clinical literature as possible, and meticulously annotating all of the available data to draw a more comprehensive conclusion. You can’t just read one or two trials, the microbiome is too complex, and the data is less consistent with a small sample size. But when you read everything, then it becomes more clear. 

In our world as it is, we all now have to be our own health advocates. With a broken government, food and medical system, you need to take charge of your healthcare. So, educate yourself, as best you can. This is why I’ve launched my educational platform. For you. You can find my presentation entitled, “SIBO – A More Intelligent Way to View and Tackle Small Intestinal Bacterial Overgrowth” in my Microbiome University tab, and also on my YouTube channel. If you have a condition or disease that you think would be well served by addressing your microbiome, you can visit the Protocols tab on my website where you can find a science-based protocol which may dramatically improve your quality of life, as they have done for many others (see my testimonials) 

The references cited within this video presentation 

Epidemiology of small intestinal bacterial overgrowth – PubMed (nih.gov) 

Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy – PubMed (nih.gov) 

Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis – PubMed (nih.gov) 

Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth – PubMed (nih.gov) 

Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth – PubMed (nih.gov) 

Dysmotility and ppi use are independent risk factors for small intestinal bacterial and/or fungal overgrowth – PMC (nih.gov) 

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics – PubMed (nih.gov) 

Personality, Anxiety, and Stress in Patients with Small Intestine Bacterial Overgrowth Syndrome. The Polish Preliminary Study – PubMed (nih.gov) 

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy – PubMed (nih.gov) 

Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H2 or CH4 production with severity of IBS – PubMed (nih.gov) 

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update – PubMed (nih.gov) 

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome – PubMed (nih.gov) 

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023? – PubMed (nih.gov) 

Share the Post:

Related Posts